← Eichor
Study identifier: NCT05884658 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Hysterectomy by Transvaginal Natural Orifice Transluminal Endoscopic Surgery Versus or Laparoscopic Hysterectomy

Condition: Hysterectomy, Vaginal  ·  Sponsor: Centre Hospitalier Universitaire de Saint Etienne

PhaseNA
Planned participants200
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

In France, there are approximately 62,000 hysterectomies per year, 70% of which are benign. It is the most frequent surgical procedure in gynecology. Hysterectomies are performed via 3 routes: laparotomy, laparoscopy or vaginal route. This choice of approach is particularly important in the case of large uteri (50% of uteri \> 280g), which increase the risks of laparoconversion and bladder injury (NP3). The vaginal route reduces the operating time and postoperative pain. Laparoscopy allows a better anatomical view and easier access to the neighbouring organs, which makes it the preferred approach, especially for young surgeons and when the uterus is large. However, the laparoscopic route is associated with an increase in the rate of conversion to laparotomy according to the volume of the uterus, as well as the rate of general per and postoperative complications compared with vaginal hysterectomy for uteri \> 280 g. In a meta-analysis comparing laparoscopy and vaginal hysterectomy, the total prevalence of perioperative complications according to the classification of Clavien and Dindo was 27%. For large uteruses, complications by the vaginal route amounted to 15% and those by the laparoscopic route to 37.5%. The data are not sufficient to give preference to one or other of the approaches, but for benign pathologies, for large uteri (\>280 g), the minimally invasive laparoscopic or vaginal approaches are recommended by the CNGOF (grade C). A new Medical Device (MD), the vN…

This description comes directly from the study's public registry record.

Talk to the study team

Céline CHAULEUR, PhD  ·  0477828383  ·  celine.chauleur@chu-st-etienne.fr

Florence RANCON  ·  0477829458  ·  florence.rancon@chu-st-etienne.fr

Always discuss trial participation with your own doctor first.

Locations (6)

HFME - Hospices Civils de LyonBron, FranceNot Yet Recruiting
CHU Clermont-FerrandClermont-Ferrand, FranceRecruiting
Ch IssoireIssoire, FranceNot Yet Recruiting
CHU LIMOGES - Hôpital de la mère et de l'EnfantLimoges, FranceNot Yet Recruiting
CHU Saint-EtienneSaint-Etienne, FranceNot Yet Recruiting
Clinique Mutualiste de Saint-EtienneSaint-Etienne, FranceNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05884658